Cargando…

The neuropeptide genes SST, TAC1, HCRT, NPY, and GAL are powerful epigenetic biomarkers in head and neck cancer: a site-specific analysis

BACKGROUND: Staging and pathological grading systems are convenient but imperfect predictors of recurrence in head and neck squamous cell carcinoma (HNSCC). Identifying biomarkers for HNSCC that will progress and cause death is a critical research area, particularly if the biomarker can be linked to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Misawa, Kiyoshi, Mima, Masato, Imai, Atsushi, Mochizuki, Daiki, Misawa, Yuki, Endo, Shiori, Ishikawa, Ryuji, Kanazawa, Takeharu, Mineta, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896056/ https://www.ncbi.nlm.nih.gov/pubmed/29682090 http://dx.doi.org/10.1186/s13148-018-0485-0

Ejemplares similares

Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis
por: Misawa, Kiyoshi, et al.
Publicado: (2017)

Neuropeptide receptor genes GHSR and NMUR1 are candidate epigenetic biomarkers and predictors for surgically treated patients with oropharyngeal cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Association of TET3 epigenetic inactivation with head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2016)

Epigenetic modification of SALL1 as a novel biomarker for the prognosis of early stage head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2017)

G Protein-Coupled Receptor Genes, PTGDR1, PTGDR2, and PTGIR, Are Candidate Epigenetic Biomarkers and Predictors for Treated Patients with HPV-Associated Oropharyngeal Cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation
por: Mochizuki, Daiki, et al.
Publicado: (2018)

Genes Located on 18q23 Are Epigenetic Markers and Have Prognostic Significance for Patients with Head and Neck Cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2019)

Late recurrence of breast carcinoma metastasis to the hypopharynx: a case report
por: Izumi, Chisako, et al.
Publicado: (2016)

Analysis of Site-Specific Methylation of Tumor-Related Genes in Head and Neck Cancer: Potential Utility as Biomarkers for Prognosis
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

Primary combined small and squamous cell carcinoma of the hypopharynx: A case report
por: MISAWA, KIYOSHI, et al.
Publicado: (2016)

Aberrant Methylation Inactivates Somatostatin and Somatostatin Receptor Type 1 in Head and Neck Squamous Cell Carcinoma
por: Misawa, Kiyoshi, et al.
Publicado: (2015)

5-Hydroxymethylcytosine and ten-eleven translocation dioxygenases in head and neck carcinoma
por: Misawa, Kiyoshi, et al.
Publicado: (2019)

Long interspersed nuclear element 1 hypomethylation has novel prognostic value and potential utility in liquid biopsy for oral cavity cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Telomere shortening in head and neck cancer: association between DNA demethylation and survival
por: Yamada, Satoshi, et al.
Publicado: (2021)

Human papillomavirus-associated small cell carcinoma/neuroendocrine carcinoma of the oropharynx: a report of two cases
por: Misawa, Kiyoshi, et al.
Publicado: (2016)

Identification of novel methylation markers in HPV-associated oropharyngeal cancer: genome-wide discovery, tissue verification and validation testing in ctDNA
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Lack of Association Between Variants within the AHSG , HCRT and NPY2R Genes and Anthropometrical Parameters in Czech Post-Monica Study
por: Jurcikova, L, et al.
Publicado: ( 201)

Epigenetic inactivation of galanin receptors in salivary duct carcinoma of the parotid gland: Potential utility as biomarkers for prognosis
por: Kanazawa, Takeharu, et al.
Publicado: (2018)

Therapeutic potential of neuropeptide Y (NPY) receptor ligands
por: Brothers, Shaun P, et al.
Publicado: (2010)

Targeted Deletion of Neuropeptide Y (NPY) Modulates Experimental Colitis
por: Chandrasekharan, Bindu, et al.
Publicado: (2008)

G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?
por: Kanazawa, Takeharu, et al.
Publicado: (2015)

Neuropeptide Y (NPY) intranasal delivery alleviates Machado–Joseph disease
por: Duarte-Neves, Joana, et al.
Publicado: (2021)

Opiate anticipation, opiate induced anatomical changes in hypocretin (Hcrt, orexin) neurons and opiate induced microglial activation are blocked by the dual Hcrt receptor antagonist suvorexant, while opiate analgesia is maintained
por: McGregor, Ronald, et al.
Publicado: (2023)

The Neuropeptides of Ocular Immune Privilege, α-MSH and NPY, Suppress Phagosome Maturation in Macrophages
por: Benque, Isaac J., et al.
Publicado: (2018)

Characterisation of Neuropeptide Y Receptor Subtypes by Synthetic NPY Analogues and by Anti-receptor Antibodies‡
por: Eckard, Christophe P., et al.
Publicado: (2001)

Mapping of the transcription start site (TSS) and identification of SNPs in the bovine neuropeptide Y (NPY) gene
por: Bahar, Bojlul, et al.
Publicado: (2008)

Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y(1) receptor: implications for migraine
por: Oliveira, Margarida-Martins, et al.
Publicado: (2016)

Anesthetic drugs modulate feeding behavior and hypothalamic expression of the POMC polypeptide precursor and the NPY neuropeptide
por: Besnier, E., et al.
Publicado: (2018)

Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1
por: Ortiz, Cristina, et al.
Publicado: (2023)

Rare case of malignant transformation of recurrent respiratory papillomatosis associated with human papillomavirus type 6 infection and p53 overexpression
por: Kanazawa, Takeharu, et al.
Publicado: (2013)

The Roles of Neuropeptide Y (Npy) and Peptide YY (Pyy) in Teleost Food Intake: A Mini Review
por: Assan, Daniel, et al.
Publicado: (2021)

Neuropeptide Y directly reduced apoptosis of granulosa cells, and the expression of NPY and its receptors in PCOS subjects
por: Urata, Yoko, et al.
Publicado: (2023)

Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer’s Disease
por: Schmidt, Frank M., et al.
Publicado: (2013)

Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
por: Bruinstroop, Eveline, et al.
Publicado: (2012)

Neuropeptide Y2 Receptor (NPY2R) Expression in Saliva Predicts Feeding Immaturity in the Premature Neonate
por: Maron, Jill L., et al.
Publicado: (2012)

Neuropeptide Y Knockout Mice Reveal a Central Role of NPY in the Coordination of Bone Mass to Body Weight
por: Baldock, Paul A., et al.
Publicado: (2009)

Association between human papillomavirus particle production and the severity of recurrent respiratory papillomatosis
por: Yamada, Satoshi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_93glmqaktlngsql2c05ti3g82m